The Japanese Biochemical Society/The Molecular Biology Society of Japan

[3LBA-124] In silico drug screening by using genome-wide association study (GWAS)-data identified a novel disease-modifying drug for Parkinson's disease

〇Takeshi Uenaka1, Wataru Satake1, Pei-Chieng Cha1, Hideki Hayakawa2, Kousuke Baba2, Kazuhiro Kobayashi1, Motoi Kanagawa1, Yukinori Okada3, Hideki Mochizuki2, Tatsushi Toda1 (1.Dept. of Neurol., Grad. Sch. of Med., Univ. of Kobe, 2.Dept. of Neurol., Grad. Sch. of Med., Univ. of Osaka, 3.Dept. of Statistical Genetics., Grad. Sch. of Med., Univ. of Osaka)

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password